Search research articles
Contact Us
Filters
Showing results (21-30 of 61) with videos related to
Page
of 7
Sort By:
Toxicology
|
July 16, 2022
A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay - Exemplified for nine compounds
Tanja M Gampfer, Lea Wagmann, Benedikt Pulver, et al.
Metabolites
|
September 24, 2020
Comparison of Three Untargeted Data Processing Workflows for Evaluating LC-HRMS Metabolomics Data
Selina Hemmer, Sascha K Manier, Svenja Fischmann, et al.
Journal of Analytical Toxicology
|
February 6, 2020
Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-Fentanyl
Tanja M Gampfer, Lea Wagmann, Matthias J Richter, et al.
Drug Testing and Analysis
|
June 23, 2019
Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens
Belal Haschimi, Lukas Mogler, Sebastian Halter, et al.
Steroids
|
February 12, 2011
Seized designer supplement named "1-Androsterone": identification as 3β-hydroxy-5α-androst-1-en-17-one and its urinary elimination
Maria K Parr, Georg Opfermann, Hans Geyer, et al.
Drug Testing and Analysis
|
August 18, 2020
Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis
|
April 3, 2024
Analytical and behavioral characterization of 1-dodecanoyl-LSD (1DD-LSD)
Pierce V Kavanagh, Folker Westphal, Benedikt Pulver, et al.
Drug Testing and Analysis
|
September 22, 2022
A new synthetic cathinone: 3,4-EtPV or 3,4-Pr-PipVP? An unsuccessful attempt to circumvent the German legislation on new psychoactive substances
Benedikt Pulver, Jan Riedel, Folker Westphal, et al.
Drug Testing and Analysis
|
October 15, 2013
The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.)
Markus R Meyer, Sandra Mauer, Golo M J Meyer, et al.
Drug Testing and Analysis
|
November 27, 2021
Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 61) with videos related to
Sort By:
Page
of 7
Toxicology
|
July 16, 2022
A simplified strategy to assess the cytotoxicity of new psychoactive substances in HepG2 cells using a high content screening assay - Exemplified for nine compounds
Tanja M Gampfer, Lea Wagmann, Benedikt Pulver, et al.
Metabolites
|
September 24, 2020
Comparison of Three Untargeted Data Processing Workflows for Evaluating LC-HRMS Metabolomics Data
Selina Hemmer, Sascha K Manier, Svenja Fischmann, et al.
Journal of Analytical Toxicology
|
February 6, 2020
Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-Fentanyl
Tanja M Gampfer, Lea Wagmann, Matthias J Richter, et al.
Drug Testing and Analysis
|
June 23, 2019
Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens
Belal Haschimi, Lukas Mogler, Sebastian Halter, et al.
Steroids
|
February 12, 2011
Seized designer supplement named "1-Androsterone": identification as 3β-hydroxy-5α-androst-1-en-17-one and its urinary elimination
Maria K Parr, Georg Opfermann, Hans Geyer, et al.
Drug Testing and Analysis
|
August 18, 2020
Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, et al.
Drug Testing and Analysis
|
April 3, 2024
Analytical and behavioral characterization of 1-dodecanoyl-LSD (1DD-LSD)
Pierce V Kavanagh, Folker Westphal, Benedikt Pulver, et al.
Drug Testing and Analysis
|
September 22, 2022
A new synthetic cathinone: 3,4-EtPV or 3,4-Pr-PipVP? An unsuccessful attempt to circumvent the German legislation on new psychoactive substances
Benedikt Pulver, Jan Riedel, Folker Westphal, et al.
Drug Testing and Analysis
|
October 15, 2013
The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.)
Markus R Meyer, Sandra Mauer, Golo M J Meyer, et al.
Drug Testing and Analysis
|
November 27, 2021
Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD)
Simon D Brandt, Pierce V Kavanagh, Folker Westphal, et al.
Page
of 7